Diplomat Announces 2nd Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Diplomat Pharmacy (DPLO) Tops Q2 EPS by 4c; Raises Outlook
August 3, 2015 4:21 PM EDTDiplomat Pharmacy (NYSE: DPLO) reported Q2 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $808 million versus the consensus estimate of $738.99 million.
Diplomat Pharmacy sees FY2015 EPS of $0.56-$0.60, versus prior guidance of $0.48-$0.51 and the consensus of... More
